Home >> Industry News >> Vitros HIV Combo test gets expanded approval

Vitros HIV Combo test gets expanded approval

image_pdfCreate PDF

Nov. 30, 2018Ortho Clinical Diagnostics announced that its Vitros Immunodiagnostic Products HIV Combo Reagent Pack and Calibrator received FDA approval for use on the company’s Vitros ECi/ECiQ Immunodiagnostic Systems. Vitros HIV Combo, a fourth-generation test, detects HIV-1 and HIV-2 antibodies (Ab) and the p24 antigen (Ag).

“Early detection of HIV-1 is critical in getting patients into treatment as soon as possible after infection,” Jennifer Paine, Ortho’s chief product portfolio and quality, regulatory, and compliance officer, said in a press release. “Ortho is proud to be working to deliver our Vitros HIV Combo test to customers worldwide.”

CAP TODAY
X